Bristol Myers Squibb

AI is more than a technology; it’s a catalyst for deeper insights, faster decisions and stronger collaboration across our teams.  In his latest article, Robert Plenge reflects on AI’s impact on R&D, what it means to lead in this new era of collaborative hybrid intelligence and how AI elevates the role of researchers like never before: https://lnkd.in/dJssRwkB #AIAppreciationDay #OneBMS

I recently had the pleasure of joining Noah Kravitz on the NVIDIA podcast to discuss the role AI is beginning to play in transforming biopharma, and the work we're doing at Bristol Myers Squibb to bring its promise to life.   We talked about a few ways AI is already making a difference at BMS:  1. Revealing hidden patterns in chemical and biological data to speed up drug discovery 2. Powering predictive models that use historical data to predict the likelihood of success for new hypotheses, speeding up drug development 3. Supercharging operations across nearly every facet of our work, often helping us accomplish in seconds what used to take hours    As I told Noah, there’s really never been a more exciting time to be a technologist in the life sciences. I invite you to listen in: https://lnkd.in/eNKwiykw  

The cornerstone of our R&D organization is our strategy – how we approach research and development and the extraordinary people that put it into practice. Across mountains, oceans and continents, our global R&D team is equipped to quickly and efficiently address the needs of patients living with difficult-to-treat diseases worldwide. From exploring causal human biology to fight cancer in Seattle – like scientist Erin Nevius – to accelerating patient access to medicines worldwide, check out the unique capabilities of our R&D hubs through the lens of our guiding principles: https://bit.ly/4nKSyrL #OneBMS

Go inside our new RayzeBio isotope production and drug manufacturing facility in Indianapolis and learn why it's the first-of-its-kind model in the U.S.: https://bit.ly/3IvLWgB #OneBMS

Here's why I'm cycling 300+ km in Japan: Like so many of us, I’ve seen the impact cancer can have — on families, friends, on lives. This October, I will be joining over 60 colleagues from 7 different countries, and we will be cycling a combined 1,800 KM across Japan as part of the Continent 2 Continent 4 Cancer (C2C4C) initiative with my colleagues at Bristol Myers Squibb, to help Raise Funds to Advance Cancer Research and Patient Focused Care I’ve been training over the past few months to make that ride happen in October and will continue through September to prepare for this meaningful journey All donations will go toward supporting Tata Memorial Hospital, Mumbai, a leading institution in cancer care and research in India 🏥 and with your support we can help change someone’s tomorrow. Please help us reach our fundraising goal. Every contribution – Rupee, Dollar or Euro – counts! 🔗 Link to the donation page: https://lnkd.in/did7Qapm 📍 Please note: The platform supports credit and debit cards only (UPI is not available).  Everybody deserves a second chance. Thank you for standing with me in this effort. 💙 #C2C4C #BMS_employee #ProudtobeBMS 

“It really did let me know that there’s almost nothing I can’t accomplish if I’m not willing to put my head down and try.” Cari Almo Gallman, EVP, General Counsel and Chief Policy Officer, shares her inspirational story of facing adversity, including her mother’s illness, emphasizing the power of reframing challenges into resilience and strength. Watch the latest episode of Trials to Transformation to hear her story. https://bit.ly/4lxWtWU #TrialstoTransformation

As the Global Lead of the Disability Advancement Workplace Network (DAWN) at Bristol Myers Squibb, I’m proud to help launch our recognition of Disability Pride Month—a time to celebrate the contributions, creativity, and lived experiences of people with disabilities.     This year, our theme is BELIEVE, which reflects our commitment to building a culture where everyone is empowered to thrive, and where disability inclusion is not just acknowledged, but actively championed.    Throughout July, DAWN is creating space for reflection, storytelling, and creative expression—amplifying voices and perspectives that too often go unheard. From global conversations to artistic showcases, we’re inviting colleagues to explore what it means to believe in themselves and in each other.    Our keynote event, “BELIEVE in Possibility, Purpose and Progress,” will feature two extraordinary voices: Eric LeGrand, a powerful advocate for people with paralysis, and Mandy Harvey, an award-winning deaf singer and songwriter whose story continues to inspire.    Disability inclusion is not a moment—it’s a movement. And I’m honored to be part of a company that believes in leading it.     What does BELIEVE mean to you?    #DisabilityPrideMonth #ProudToBeBMS 

Despite the complexity of cancer, our team is committed to transforming patients’ lives through science, including continued research in dual immunotherapy treatment. We’re looking forward to sharing new clinical data at the European Society for Medical Oncology Gastrointestinal Cancers Congress. Learn more about our work in oncology: https://bit.ly/4npuESq #ESMOGI25 #OneBMS

Our toughest days on the job are often the most defining. In the latest episode of our Trials to Transformation series, CEO Chris Boerner sits down with EVP, General Counsel and Chief Policy Officer Cari Almo Gallman to share why it can actually be a gift when things go wrong. Watch to learn more. https://bit.ly/3I49DML #TrialstoTransformation #OneBMS